aTyr Pharma, Inc. (ATYR)
USD 3.15
(2.27%)
USD 3.15
(2.27%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 353 Thousand | 10.38 Million | - | 10.45 Million | 422 Thousand | - |
| Cost of Revenue | 2.74 Million | 1.69 Million | 1.3 Million | 17.29 Million | 14.04 Million | 746 Thousand |
| Gross Profit | -2.38 Million | 8.69 Million | -1.3 Million | -6.83 Million | -13.62 Million | -746 Thousand |
| Operating Expenses | 12.97 Million | 55.09 Million | 32.71 Million | 25.1 Million | 22.03 Million | 32.07 Million |
| Selling, General and Administrative Expenses | 12.97 Million | 12.28 Million | 9.44 Million | 7.8 Million | 7.98 Million | 11.68 Million |
| Research and Development Expenses | 42.29 Million | 42.8 Million | 23.26 Million | 17.29 Million | 14.04 Million | 20.38 Million |
| Other Expenses | - | 1.06 Million | 238 Thousand | -319 Thousand | - | - |
| Cost and Expenses | 55.27 Million | 56.79 Million | 34.01 Million | 26.36 Million | 23.4 Million | 32.82 Million |
| Operating Income | -54.91 Million | -46.4 Million | -34.01 Million | -15.91 Million | -22.97 Million | -32.82 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -5000.00 | -9000.00 | -6000.00 | -160 Thousand | 1.00 |
| Earnings before Tax | -50.39 Million | -45.34 Million | -33.77 Million | -16.23 Million | -23.76 Million | -34.51 Million |
| Net Income | -50.38 Million | -45.33 Million | -33.76 Million | -16.22 Million | -23.6 Million | -34.51 Million |
| Earnings Per Share Basic | -0.94 | -1.60 | -1.77 | -1.77 | -7.03 | -16.13 |
| Earnings Per Share Diluted | -0.94 | -1.60 | -1.77 | -1.77 | -7.03 | -16.13 |
| Weighted Average Shares Outstanding | 53.6 Million | 28.41 Million | 19.08 Million | 9.16 Million | 3.35 Million | 2.13 Million |
| Weighted Average Shares Outstanding (Diluted) | 53.6 Million | 28.41 Million | 19.08 Million | 9.16 Million | 3.35 Million | 2.13 Million |
| Gross Margin | -6.76 | 0.84 | - | -0.65 | -32.29 | - |
| EBIT Margin | -147.81 | -4.30 | - | -1.40 | -51.21 | - |
| Profit Margin | -142.75 | -4.37 | - | -1.55 | -55.93 | - |
| EBITDA | -52.17 Million | -44.7 Million | -32.47 Million | -14.64 Million | -21.61 Million | -32.07 Million |
| Earnings Before Tax Margin | -155.58 | -4.47 | - | -1.52 | -54.45 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | 235 Thousand | 353 Thousand | - | 353 Thousand | - |
| Cost of Revenue | 383 Thousand | 770 Thousand | 2.74 Million | 407 Thousand | 993 Thousand | 586 Thousand |
| Gross Profit | -383 Thousand | -535 Thousand | -2.38 Million | -407 Thousand | -640 Thousand | -586 Thousand |
| Operating Expenses | 16.93 Million | 16.1 Million | 52.53 Million | 15.55 Million | 11.97 Million | 12.97 Million |
| Selling, General and Administrative Expenses | 2.95 Million | 2.73 Million | - | 2.79 Million | 1.65 Million | 3.13 Million |
| Research and Development Expenses | 13.97 Million | 13.36 Million | - | 12.75 Million | 10.31 Million | 9.84 Million |
| Other Expenses | 1 Million | 1.14 Million | 4.52 Million | 1.19 Million | 1.27 Million | 1.21 Million |
| Cost and Expenses | 17.31 Million | 16.87 Million | 55.27 Million | 15.95 Million | 12.96 Million | 13.55 Million |
| Operating Income | -17.31 Million | -16.63 Million | -54.91 Million | -15.95 Million | -12.61 Million | -13.55 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -1.00 | 4000.00 | -8000.00 | -1000.00 | -2000.00 | -4000.00 |
| Earnings before Tax | -16.3 Million | -15.48 Million | -50.39 Million | -14.76 Million | -11.34 Million | -12.34 Million |
| Net Income | -16.3 Million | -15.49 Million | -50.38 Million | -14.76 Million | -11.34 Million | -12.33 Million |
| Earnings Per Share Basic | -0.23 | -0.23 | - | -0.25 | -0.20 | -0.22 |
| Earnings Per Share Diluted | -0.23 | -0.23 | - | -0.25 | -0.20 | -0.22 |
| Weighted Average Shares Outstanding | 72.28 Million | 66.08 Million | 53.6 Million | 59.26 Million | 57.88 Million | 55.14 Million |
| Weighted Average Shares Outstanding (Diluted) | 72.28 Million | 66.08 Million | 53.6 Million | 59.26 Million | 57.88 Million | 55.14 Million |
| Gross Margin | - | -2.28 | -6.76 | - | -1.81 | - |
| EBIT Margin | - | -67.51 | - | - | -32.92 | - |
| Profit Margin | - | -65.92 | -142.75 | - | -32.12 | - |
| EBITDA | -16.93 Million | -15.86 Million | - | -15.55 Million | -11.62 Million | -12.97 Million |
| Earnings Before Tax Margin | - | -70.79 | -155.58 | - | -35.74 | - |
6876
PBI
HL
002795
ARC
015260